Skip to content

Oric Pharmaceuticals, Inc. ORIC Software and Technology Licenses, Net

Software and Technology Licenses, Net at other companies

Pfizer logo
PfizerPFE
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
CG Oncology logo
CG OncologyCGON
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
Arcus Biosciences logo
Arcus BiosciencesRCUS
Erasca, Inc. logo
Erasca, Inc.ERAS

Other financials

Income statement

See full
Operating income-$39.6M-21.1%
Net income-$35.8M-19.1%
EPS (diluted)-$0.34+19.0%

Balance sheet

See full
Cash & equivalents$56.4M+14.3%
Total debt$3.3M+2.6%
Total equity$415.6M+89.1%
Total assets$436.8M+79.8%

Cash flow

See full
Operating cash flow-$32.4M+0.3%
CapEx$2.0K-99.5%
Free cash flow-$32.4M+1.5%

Valuation

See full
Market cap$976.17M+23.0%
Enterprise value$923.07M+23.5%

Returns & leverage

See full
Return on equity-42.6%-4.6pp
Debt / equity0.0×
Current ratio16.3×+4.3×

Where this comes from

Reported directly by Oric Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Oric Pharmaceuticals, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oric Pharmaceuticals, Inc.'s software and technology licenses, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oric Pharmaceuticals, Inc.'s software and technology licenses, net?
Oric Pharmaceuticals, Inc. (ORIC) reported software and technology licenses, net of $6.6M in Q1 2026.
How has Oric Pharmaceuticals, Inc.'s software and technology licenses, net changed year-over-year?
Oric Pharmaceuticals, Inc.'s software and technology licenses, net decreased by 21.1% year-over-year, from $8.37M to $6.6M.
What is the long-term trend for Oric Pharmaceuticals, Inc.'s software and technology licenses, net?
Over 5 years (2020 to 2025), Oric Pharmaceuticals, Inc.'s software and technology licenses, net has grown at a 86.8% compound annual growth rate (CAGR), from $319K to $7.25M.